- Home
- DOCN vs OGN Comparison
DOCN vs OGN Comparison
Compare DOCN & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DOCN
- OGN
- Stock Information
- Founded
- DOCN 2011
- OGN 1923
- Country
- DOCN United States
- OGN United States
- Employees
- DOCN N/A
- OGN N/A
- Industry
- DOCN Retail: Computer Software & Peripheral Equipment
- OGN Biotechnology: Pharmaceutical Preparations
- Sector
- DOCN Technology
- OGN Health Care
- Exchange
- DOCN Nasdaq
- OGN Nasdaq
- Market Cap
- DOCN 3.5B
- OGN 3.9B
- IPO Year
- DOCN 2021
- OGN N/A
- Fundamental
- Price
- DOCN $35.74
- OGN $14.50
- Analyst Decision
- DOCN Buy
- OGN Hold
- Analyst Count
- DOCN 10
- OGN 3
- Target Price
- DOCN $42.11
- OGN $21.33
- AVG Volume (30 Days)
- DOCN 788.7K
- OGN 4.5M
- Earning Date
- DOCN 11-04-2024
- OGN 02-13-2025
- Dividend Yield
- DOCN N/A
- OGN 7.68%
- EPS Growth
- DOCN N/A
- OGN 120.97
- EPS
- DOCN 0.87
- OGN 5.04
- Revenue
- DOCN $756,564,000.00
- OGN $6,409,000,000.00
- Revenue This Year
- DOCN $14.25
- OGN $3.11
- Revenue Next Year
- DOCN $13.03
- OGN $2.55
- P/E Ratio
- DOCN $40.86
- OGN $2.89
- Revenue Growth
- DOCN 12.08
- OGN 4.21
- 52 Week Low
- DOCN $26.63
- OGN $13.58
- 52 Week High
- DOCN $44.80
- OGN $23.10
- Technical
- Relative Strength Index (RSI)
- DOCN 38.85
- OGN 37.20
- Support Level
- DOCN $37.97
- OGN $14.39
- Resistance Level
- DOCN $39.50
- OGN $15.15
- Average True Range (ATR)
- DOCN 1.57
- OGN 0.52
- MACD
- DOCN -0.36
- OGN -0.02
- Stochastic Oscillator
- DOCN 17.58
- OGN 8.63
About DOCN DigitalOcean Holdings Inc.
DigitalOcean Holdings Inc is a cloud computing platform offering on-demand infrastructure and platform tools for developers, start-ups and small and medium-sized businesses. The customers use the platform for a wide range of cases, such as web and mobile applications, website hosting, e-commerce, media and gaming, personal web projects, and managed services, among many others. The group has a business presence in North America, Europe, Asia and Other countries.
About OGN Organon & Co.
Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars, and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.